Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6

Optimizing medicines management: From compliance to concordance

Authors Annie Cushing, Richard Metcalfe

Published 15 January 2008 Volume 2007:3(6) Pages 1047—1058

Annie Cushing1, Richard Metcalfe2
1Clinical and Communication Skills Unit, Barts and the London, Queen Mary’s School of Medicine and Dentistry, University of London, London, England, UK; 2Department of Neurology, Institute of Neurological Sciences, Southern General Hospital,
Glasgow, Scotland, UK
Abstract: Medication prescribed but not consumed represents a huge loss in drug and prescribing costs and an enormous waste of expensive medical time. In this article we discuss what is known about compliance and adherence, explore the concept of concordance and demonstrate its fundamental difference from both. Not all patients are ready or suitable for shared decision making in management of their condition, some still preferring a doctor-led decision but an increasing number want a partnership approach. By opening up and rebalancing the discussion about medication, we can expect a consultation which is more satisfying for both parties and flowing from this, more effective, focused prescribing of medication which is more likely to be adhered to by the patient. We examine the extent to which doctor and patient behaviors are currently compatible with this change of concept and practice, look at available consultation models which might be useful to the reflective practitioner and consider what actions on the part of the doctor and the healthcare system could promote medicine prescription and utilization in line with this new approach based on partnership.
Keywords: concordance, patient participation, decision making, adherence, physician-patient relations, communication

Download Article [PDF] 

Readers of this article also read:

BMP2-loaded hollow hydroxyapatite microspheres exhibit enhanced osteoinduction and osteogenicity in large bone defects

Xiong L, Zeng J, Yao A, Tu Q, Li J, Yan L, Tang Z

International Journal of Nanomedicine 2015, 10:517-526

Published Date: 12 January 2015

The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective

Chen HY, Saczynski JS, McManus DD, Lessard D, Yarzebski J, Lapane KL, Gore JM, Goldberg RJ

Clinical Epidemiology 2013, 5:439-448

Published Date: 7 November 2013

A peptide-mediated targeting gene delivery system for malignant glioma cells

Wang C, Ning L, Wang H, Lu Z, Li X, Fan X, Wang X, Liu Y

International Journal of Nanomedicine 2013, 8:3631-3640

Published Date: 24 September 2013

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing

Christoforidis JB, Wang J, Jiang A, Willard J, Pratt C, Abdel-Rasoul M, Roy S, Powell HM

Clinical Ophthalmology 2013, 7:185-191

Published Date: 24 January 2013

Treatment of severe psoriasis with infliximab

JA Leman, AD Burden

Therapeutics and Clinical Risk Management 2008, 4:1165-1175

Published Date: 5 December 2008

Posaconazole in the management of refractory invasive fungal infections

Stefan Langner, Philipp B Staber, Peter Neumeister

Therapeutics and Clinical Risk Management 2008, 4:747-757

Published Date: 8 August 2008

Potential bias in ophthalmic pharmaceutical clinical trials

Paul Varner

Clinical Ophthalmology 2008, 2:401-411

Published Date: 6 June 2008